Trials / Sponsors / Sarcoma Oncology Research Center, LLC

Sarcoma Oncology Research Center, LLC

Academic / Other · 9 registered clinical trials — 4 currently recruiting.

Status	Trial	Phase	Started
Withdrawn	A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma Soft Tissue Sarcoma	Phase 2	2024-08-01
Withdrawn	Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures Sarcoma	—	2023-01-27
Recruiting	Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma Leiomyosarcoma	Phase 2	2021-09-09
Recruiting	GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma Sarcoma	Phase 2	2020-09-30
Active Not Recruiting	SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma Sarcoma, Ewing, Sarcoma	Phase 2	2020-01-03
Active Not Recruiting	Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors Solid Tumor, Adult, Soft Tissue Sarcoma, Non Small Cell Lung Cancer	Phase 1 / Phase 2	2019-10-17
Recruiting	Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma Sarcoma	Phase 2	2019-05-15
Completed	Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Ewing Sarcoma, PEComa, Epithelioid Sarcoma	Phase 1 / Phase 2	2017-08-24
Recruiting	SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma	Phase 1 / Phase 2	2017-04-13